Suppr超能文献

人肝脏中胆汁酸合成的反馈调节:肝细胞核因子4α对细胞色素P450 7A1调节的重要性。

Feedback regulation of bile acid synthesis in human liver: importance of HNF-4alpha for regulation of CYP7A1.

作者信息

Abrahamsson Anna, Gustafsson Ulf, Ellis Ewa, Nilsson Lisa-Mari, Sahlin Staffan, Björkhem Ingemar, Einarsson Curt

机构信息

Department of Medicine, Division of Gastroenterology and Hepatology, Karolinska Institute K63, Karolinska University Hospital Huddinge, S-14186 Stockholm, Sweden.

出版信息

Biochem Biophys Res Commun. 2005 May 6;330(2):395-9. doi: 10.1016/j.bbrc.2005.02.170.

Abstract

A great number of nuclear factors are involved in the negative feedback mechanism regulating bile acid synthesis. There are two major ways for the negative feedback to effect the synthesis; the SHP-dependent, involving FXR, and the SHP-independent way, affecting HNF-4alpha. We studied 23 patients with gallstone disease. Eight patients were treated with chenodeoxycholic acid, 7 with cholestyramine prior to operation, and 8 served as controls. Liver biopsies were analyzed with Real-time-PCR. In the cholestyramine-treated group mRNA levels of CYP7A1 were increased about 10-fold. Treatment with CDCA decreased the mRNA levels of CYP7A1 by about 70%. The mRNA levels of CYP8B1, CYP27A1, and CYP7B1 were not significantly altered in the treated groups. The analysis of mRNA levels for HNF-4alpha showed 64% higher levels in the cholestyramine-treated group compared to the controls. These levels showed positive and highly significant correlation to the levels of mRNA of CYP7A1 when studied in all three groups together. FXR, SHP, and LRH-1/FTF were not significantly affected by the different treatments. Our results indicate that when bile acid synthesis is upregulated by cholestyramine treatment the SHP-independent pathway for controlling CYP7A1 transcription dominates over the SHP-dependent pathway.

摘要

大量核因子参与调节胆汁酸合成的负反馈机制。负反馈影响合成有两种主要方式;依赖小异二聚体伴侣(SHP)的方式,涉及法尼酯X受体(FXR),以及不依赖SHP的方式,影响肝细胞核因子4α(HNF-4α)。我们研究了23例胆结石病患者。8例患者术前接受鹅去氧胆酸治疗,7例接受消胆胺治疗,8例作为对照。通过实时聚合酶链反应(Real-time-PCR)分析肝活检组织。在消胆胺治疗组中,细胞色素P450 7A1(CYP7A1)的mRNA水平增加了约10倍。鹅去氧胆酸(CDCA)治疗使CYP7A1的mRNA水平降低了约70%。在治疗组中,细胞色素P450 8B1(CYP8B1)、细胞色素P450 27A1(CYP27A1)和细胞色素P450 7B1(CYP7B1)的mRNA水平没有显著改变。对HNF-4α的mRNA水平分析显示,消胆胺治疗组的水平比对照组高64%。当在所有三组中一起研究时,这些水平与CYP7A1的mRNA水平呈正相关且高度显著相关。不同治疗对FXR、SHP和肝受体同源物1/胎儿型转录因子(LRH-1/FTF)没有显著影响。我们的结果表明,当通过消胆胺治疗上调胆汁酸合成时,控制CYP7A1转录的不依赖SHP的途径比依赖SHP的途径占主导地位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验